Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.
|Number of pages||2|
|Journal||International Journal of Clinical Practice|
|Publication status||Published - 2005|
- dry powder inhalers
- generic substitution